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Abstract 
Background: Chronic obstructive pulmonary disease (COPD) exacerbations are associated with high disease burden 
and costs, especially in the case of hospitalizations. The overall number of hospital admissions due to exacerbations 
of COPD has increased. It is remarkable that re-admissions account for a substantial part of these hospitalizations. This 
pilot study investigates the use of case management to reduce re-admissions due to COPD.
Methods: COPD patients with more than one hospitalization per year due to an exacerbation were included. The 
participants (n = 10) were closely monitored and intensively coached for 20 weeks after hospitalization. The case 
manager provided care in a person-focused manner. The case manager informed and supported the patient, took 
action when relapse threatened, coordinated and connected primary and secondary care. Data of 12 months before 
and after start of the intervention were compared. Primary outcome was the difference in number of hospitalizations. 
Secondary outcomes were health-related quality of life (measured by the Clinical COPD Questionnaire, CCQ) and 
dyspnoea (measured by the MRC Dyspnoea Scale).
Results: The incidence rate of hospitalizations was found to be 2.25 times higher (95% confidence interval [CI] 
1.3–3.9; P = 0.004) 12 months before compared with 12 months after the start of case management. COPD patients 
had a mean CCQ score of 3.3 (95% CI 2.8–3.8) before and 2.4 (95% CI 1.9–2.8) after 20 weeks of case management; 
a difference of 1.0 (95% CI 0.4–1.6; P = 0.001). The mean MRC scores showed no significant differences before (4.3; 
95% CI 3.7–4.9) and after the case management period (3.9; 95% CI 3.2–4.6); a difference of 0.4 (95% CI − 0.1 to 0.9; 
P = 0.114).
Conclusions: This pilot study shows that the number of COPD hospital re-admissions decreased significantly after 
the introduction of a case manager. Moreover, there was an improvement in patient-reported health-related quality 
of life.
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Introduction
Exacerbations of chronic obstructive pulmonary dis-
ease (COPD) are associated with high disease burden 
and costs, especially in the case of hospitalizations [1]. 
In the Netherlands, the number of hospital admissions 
due to COPD exacerbations has increased [2]. However, 
it is generally assumed that many hospitalizations are 
avoidable with good ambulatory care [3]. Nevertheless, 
this type of outpatient care requires a multidisciplinary 
approach and good interaction with the patient [4].
Lung Alliance Netherlands (LAN) is a federated asso-
ciation in the field of lung diseases and coordinates the 
National Action Programme on Chronic Lung Diseases 
(NACL). The NACL should ensure improvement of pre-
vention and care for lung patients in the Netherlands. 
One of the main goals is to reduce the number of hospital 
admission days due to COPD by 25% [5].
Because re-admissions account for a substantial part 
of COPD hospitalizations, strategies are needed to avoid 
these re-admissions. Surprisingly, there is a paucity of 
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evidence to guide clinicians on how to prevent these re-
admissions [6, 7].
Prieto et  al. systematically reviewed five randomized 
clinical trials assessing interventions to reduce re-admis-
sions following COPD hospitalizations and concluded 
that there is inadequate information to recommend spe-
cific strategies to reduce the risk of hospitalizations [8].
Many factors are associated with COPD re-admissions. 
Besides disease specific factors, there are factors not spe-
cific to COPD, like comorbidities and psychosocial fac-
tors [9, 10]. It was hypothesized that a person-focused 
manner may be more efficient in preventing re-admis-
sions. In a person-focused approach, the whole person 
is considered and not just the disease [8, 11]. Case man-
agement is considered as a promising intervention, since 
care could be individualized in this model [4].
Therefore, this study investigates the effects of case 
management on COPD re-admissions and whether this 
intervention improves health-related quality of life and 
dyspnea.
Methods
Setting
This pilot study within the NACL [5] was performed 
between 2012 and 2014 in the Dutch MC Zuiderzee hos-
pital in Lelystad. Ethical approval was not required.
Participants
Patients with COPD according to the GOLD criteria 
[1], with > 1 hospitalization in the last 12 months due to 
exacerbations, were included. The only exclusion crite-
rion was severe psychiatric disorder(s) hindering COPD 
case management. All participants gave written informed 
consent.
Intervention
During 20  weeks after hospitalization, each participant 
was intensively coached and monitored by a case man-
ager. The case manager was a nurse specialized in COPD, 
who received training in person-focused care, coach-
ing and strategies associated with self-management 
education.
The initial contact took place during hospitalization. 
Main goal of this contact was to assess respiratory medi-
cations and inhaler technique prior to discharge.
After discharge, the case manager visited the patients 
five times at home. Each visit lasted approximately 
40 min. If the patient cancelled an appointment, the case 
manager contacted the patient to check whether the 
patient still wanted to participate and if so, they made 
another appointment. The case manager provided care in 
a person-focused manner. This approach considered the 
whole person, rather than focusing on the illness.
During the home visits, the patients were monitored 
regarding physical, mental, emotional and social well-
being, living situation, social network, therapy adherence, 
coping, self-management and care needs. The Clini-
cal COPD Questionnaire (CCQ) [12, 13] and the Medi-
cal Research Council Dyspnea Scale (MRC) [14] were 
administered. The case manager investigated all needs 
and made an individualized strategy for each patient. 
Proper communication was used to create conditions 
which promote self-management and a spirit of col-
laboration. The case manager inventoried exacerbating 
factors, prepared a written exacerbation action plan to 
recognize and manage exacerbations, took action when 
relapse threatened and supported the patient. The patient 
received information about (dealing with) COPD as a dis-
ease, medication, inhalation technique, physical activity, 
nutrition, and smoking cessation. Where appropriate, 
family members were involved in the education pro-
cess as well. The case manager served as a contact and 
patients were invited to call the case manager if they had 
any concerns. Furthermore, the case manager scheduled 
multidisciplinary meetings and coordinated and con-
nected primary and secondary care.
Statistical analysis
An intention-to-treat analysis was performed. Data 
acquired before and after start of the intervention were 
compared. Primary outcome was the difference in num-
ber of hospitalizations during 12  months. Secondary 
outcomes were health-related quality of life as assessed 
with the CCQ [12, 13] and dyspnea as measured with 
the MRC [14]. The last CCQ and MRC measurements of 
patients that dropped out during the study period were 
carried forward in the corresponding analysis.
Generalized estimating equation analysis was used, 
thereby taking into account the correlation within a 
patient between the periods. For the primary outcome 
we applied repeated measures Poisson regression. For the 
secondary outcomes we used the normal distribution.
The SPSS version 20 was used for statistical analyses. 
We considered a P value of less than 0.05 to be significant.
Cost analysis
A cost analysis was performed.
Results
Of the 11 selected COPD patients, one patient was 
excluded due to an anxiety disorder and refusal to allow 
visits from the case manager. Table  1 presents baseline 
characteristics of the included patients. During the inter-
vention period, one participant died due to complications 
of COPD and another patient dropped out because they 
no longer wished to participate. Two home-visits were 
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cancelled because these patients were admitted to the 
hospital. The case manager subsequently visited these 
patients during their hospitalization.
The incidence rate of hospitalizations was 2.25 times 
higher 12  months before compared with 12  months 
after start of case management, as shown in Table  2. 
There was no difference in mean duration of hospitali-
zations. After the intervention, the number of days of 
hospitalization per patient/year decreased on average by 
13.7 days.
Mean CCQ scores improved by 1.0 point after 20 weeks 
of case management. The improvement exceeds the clini-
cally relevant improvement of 0.4 points [13]. Mean MRC 
scores showed no significant differences.
Cost analysis
In this pilot study, the costs for the use of a case manager 
were 1835 euro (24  h; 76 euro/h) per patient/year. Tak-
ing implementation costs into account, the total costs of 
the case management program were approximately 3350 
euro per patient/year.
In 2013 in the Netherlands, COPD hospitalizations 
cost 498 euro per day according to the ‘national guide-
lines for pharmacy-economic research [15]’ and after 
inflation adjustment [16]. With 6.7 fewer hospital days 
per patient/year, the intervention covers costs. The pre-
sent study shows that, after case management, days in 
hospital decreased by 13.7  days. The declined hospital 
costs exceed the costs of case management, resulting in a 
net saving of €3473 per patient/year.
Discussion
In the present study, the number of hospitalizations 
due to COPD exacerbations in patients with frequent 
re-admissions decreased by 56% after introduction of a 
case manager, which contributes to one of the main goals 
of the NACL [5]. Our results are in line with the idea 
that pro-active guidance is necessary for good ambula-
tory care [17]. The case manager supports the patient 
in several ways, which eventually improves the patient’s 
self-management. Our patients were positive about the 
intervention. They indicated that they felt more inde-
pendent and had more control over their disease pro-
cess after the case management period. Their knowledge 
about disease and medication improved. They had a more 
positive outlook on life, were less anxious and accepted 
their situation more. Patients learned to take action at the 
right time, such as contacting their general practitioner 
and using medication appropriately. Besides, patients 
experienced social progress. Some participants indicated 
Table 1 Baseline characteristics of the study population 
(n = 10)
Values are presented as means (standard deviations), unless stated otherwise
FER forced expiratory ratio (FEV1/FVC × 100%), FVC forced vital capacity, FEV1 
forced expiratory volume in 1 s, post-bronchodilator, predicted according to age 
and height; GOLD global initiative for chronic obstructive pulmonary disease 
CCQ Clinical COPD Questionnaire; MRC Medical Research Council Dyspnea Scale
Men, % 20
Age in years 62.9 (9.6)
Pulmonary function
 FER% 41.7 (15.3)
 Predicted FEV1% 45.3 (28.5)
GOLD stage, %
 1 Mild: FEV1 > 80% 10
 2 Moderate: 50% ≤ FEV1 < 80% 30
 3 Severe: 30% ≤ FEV1 < 50% 10
 4 Very severe: FEV1 < 30% 50
CCQ total score 3.3 (0.8)
MRC 4.3 (1.1)
Table 2 Differences in COPD hospitalizations, CCQ and MRC scores before and after the case management period
Values are presented as means (95% confidence interval), unless stated otherwise
CCQ Clinical COPD Questionnaire, MRC Medical Research Council Dyspnea Scale
a Rate ratio
b One patient included who died after 3 months; value multiplied by 4
c Mean value after 20 weeks of case management, includes last measurements of deceased patient (after 8 weeks) and of dropped-out patient (after 12 weeks)
Outcome Usual care Case management Mean difference P value
Hospitalizations, rate per year 3.4 (2.6–4.5) 1.5 (0.9–2.5) 2.25 (1.3 to 3.9)a 0.004
Duration of hospitalization, days 7.49 (5.8–9.2) 7.53 (5.1–10.0) 0.04 (− 1.7 to 1.8) 0.961
Total days in hospital per patient per year 26 (17.2–34.8) 12.3 (5.3–19.4)b − 13.7 (− 24.5 to − 2.8) 0.013
CCQ total score 3.3 (2.8–3.8) 2.4 (1.9–2.8)c − 1.0 (− 1.6 to − 0.4) 0.001
CCQ: symptoms domain 3.3 (2.6–3.9) 2.5 (2.0–3.0)c − 0.7 (− 1.3 to − 0.2) 0.009
CCQ: functional domain 4.1 (3.5–4.6) 2.8 (2.2–3.3)c − 1.3 (− 2.1 to − 0.6) 0.001
CCQ: mental domain 2.0 (0.9–3.1) 1.2 (0.5–1.9)c − 0.8 (− 1.8 to 0.2) 0.117
MRC 4.3 (3.7–4.9) 3.9 (3.2–4.6)c − 0.4 (−0.9 to 0.1) 0.114
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that they had a better relationship with their partner and 
others enjoyed their grandchildren more.
The health-related quality of life improved with clini-
cally important differences. Since feelings of anxiety 
and depression are common among COPD patients and 
social factors play a role in some hospitalizations [5, 
9, 10], psychosocial factors need attention at an early 
stage of a case management program. A person-focused 
approach (instead of a patient-focused approach) as used 
in this study is recommended.
No differences were found in dyspnea, perhaps because 
case management does not directly affect lung function. 
After the intervention, patients experienced the same 
level of severity of dyspnea, but felt better able to deal 
with their disease as represented by an improvement on 
functional domain of the CCQ.
Limitations
This pilot study with one case manager was designed as a 
proof of concept and included only 10 participants. The 
results need to be interpreted with caution. Even in our 
small study group the results are convincing. However, 
the effect sizes might be overestimated, as regression to 
the mean was not taken into account. Therefore, future 
studies should include a control group. Nevertheless, the 
included participants had been repeatedly admitted for 
several years and were expected to have a similar number 
of hospitalizations with unchanged care. The introduc-
tion of a case manager seems to break the vicious cycle 
of re-admissions and would definitely have an effect on 
the number of hospitalizations. Due to the comprehen-
sive person-focused approach, it is difficult to pinpoint 
the particular components of the case management that 
led to the effect.
The substantial decrease in hospitalizations might be 
explained by the inclusion of COPD patients with  >  1 
hospitalization per year. Case management may also 
prove effective in other patient groups, but may be most 
(cost-) effective in those subgroups with considerable 
room for improvement.
COPD severity could play a role as well. Since patients 
with a higher burden of disease have more room for 
improvement, they might benefit more from case man-
agement. Due to the small sample size of our pilot study, 
we were unable to do subgroup analyses to analyze the 
impact of COPD severity. It would be interesting to 
investigate this in larger studies.
In Lelystad, a larger project has been started to con-
firm the present results. The number of hospitalizations 
increased after the case management period of 20 weeks 
and participants appreciated a second period with less 
frequent monitoring after the intensive monitoring 
period of 20 weeks. Based on these experiences, the case 
management period will be extended from 20  weeks to 
1  year. Participants will be visited quarterly during the 
second half year of the intervention.
Besides, the multidisciplinary meetings will be changed 
in less frequent conference calls, since the meetings were 
encountered as time consuming by the involved care 
professionals.
Our cost-analysis showed that the case management 
program resulted in a net saving. It is expected that the 
total costs of case management will decrease in the com-
ing years, especially due to less implementation costs. 
Consequently in the future, a break-even result may 
be reached with a smaller reduction in hospital days 
(< 6.7 days). A reduction in hospitalizations is favorable 
for patients and health insurance companies, however, 
hospitals may lose income and employees may lose their 
job. A transition could be introduced whereby hospital 
nurses are retrained as case managers. There might also 
be a role for health insurers to ‘reward’ care groups that 
achieve fewer hospitalizations due to effective case man-
agement. A funding model for this transmural care needs 
to be found (Additional file 1).
Conclusions
In conclusion, the current data show that case manage-
ment might be a valuable intervention to reduce COPD 
hospitalizations and to improve quality of life. More 
research is necessary to confirm these findings.
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